News & Stories

Oncology Tube Interview with Dr. David Lieberman, OHSU

Evaluating the efficacy of a noninvasive CRC screening test from CRC-PREVENT Trial Findings

Dr. David Lieberman discusses the Geneoscopy: Efficacy of Non-Invasive Colorectal Cancer Screening Test Evaluated in the CRC-PREVENT Phase 3 Trial

Related Articles

Geneoscopy Joins White House for Cancer Moonshot Colorectal Cancer Forum

March 10, 2023

Health Tech: Erica Barnell On How Geneoscopy’s Technology Can Make An Important Impact On Our Overall Wellness

March 7, 2023

Geneoscopy appoints Don Hardison to its Board of Directors

February 28, 2023

Geneoscopy Submits Premarket Approval Application to FDA for its Noninvasive Colorectal Cancer RNA Biomarker Screening Test

January 24, 2023

Geneoscopy’s Noninvasive Colorectal Cancer Screening Test Demonstrates High Sensitivity and Specificity in Large Pivotal Clinical Trial

January 10, 2023

Geneoscopy Receives Accreditation from the College of American Pathologists (CAP) for its St. Louis Clinical Laboratory

December 13, 2022